TheEdgeResearch
Home / Stocks / IVF

INVO Fertility, Inc. (IVF)

NASDAQ Healthcare Medical - Devices
$1.00 ▼ -2.91%
Market Cap
$1.8M
Sector
Healthcare
Industry
Medical - Devices
Beta
2.32
52-Wk Range
0.9-84.4
CEO
Steven Shum
Country
US
Currency
USD

INVO Fertility, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sarasota, FL, US. The stock last traded at $1.00, down 2.91% on the session, giving a market capitalisation of $1.8M. On trailing twelve-month figures it carries a trailing P/E of -0.04, a net margin of -158.7%. Its beta of 2.32 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.04
Price / Sales
0.25
Price / Book
0.11
EV / EBITDA
-0.11
Gross margin
36.9%
Operating margin
-86.3%
Net margin
-158.7%
Return on equity
Debt / equity
0.27
Current ratio
0.90
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
41
IPO date
2020-11-02
Headquarters
Sarasota, FL, US
About INVO Fertility, Inc.

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Comparable companies

INVO Fertility, Inc. is most often compared with the following Healthcare names:

AVGRAXDXCMAXCUTRNBSEONCSQONCTSAVAWSIENTMBR
More research on IVF
IVF technical analysis IVF TheEdge Score Compare against peers
Open full interactive analysis & DCF →